![Svafa Grönfeldt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Svafa Grönfeldt
Direktor/Vorstandsmitglied bei EMBLA MEDICAL HF.
Vermögen: 321 014 $ am 31.05.2025
Profil
Svafa Grönfeldt is the founder of The MET Fund LLC.
Current positions include Vice Chairman at Embla Medical hf since 2021, Director at Icelandair Group hf since 2019, Independent Director at JBT Marel Corp.
starting in 2025, and Professor at the Massachusetts Institute of Technology since 2021.
Former positions include Deputy Chief Executive Officer at Actavis Group ehf from 2002 to 2007, Director at Landsbankinn hf, Director at Origo hf from 2019 to 2021, Director at Alvogen, Inc. from 2010 to 2011, Director at Marel hf from 2021 to 2025, Managing Partner at Deloitte & Touche LLP, Assistant Professor at the University of Iceland, Member-Supervisory Board at Lotus Pharmaceutical Co., Ltd., and President at Reykjavik University from 2007 to 2010.
Education includes a graduate degree from Florida Institute of Technology, Inc. and a doctorate from the London School of Economics & Political Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.06.2025 | 1.900 ( 0 % ) | 218 139 $ | 31.05.2025 | |
ICELANDAIR GROUP HF 0,03 % | 31.12.2024 | 12.500.000 ( 0,03 % ) | 102 875 $ | 31.05.2025 |
Aktive Positionen von Svafa Grönfeldt
| Unternehmen | Position | Beginn |
|---|---|---|
| EMBLA MEDICAL HF. | Direktor/Vorstandsmitglied | 01.02.2008 |
| ICELANDAIR GROUP HF. | Direktor/Vorstandsmitglied | 08.03.2019 |
| JBT MAREL CORPORATION | Direktor/Vorstandsmitglied | 02.01.2025 |
The MET Fund LLC
 The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Gründer | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | 01.01.2021 |
Ehemalige bekannte Positionen von Svafa Grönfeldt
| Unternehmen | Position | Ende |
|---|---|---|
| MAREL HF. | Direktor/Vorstandsmitglied | 01.01.2025 |
| ORIGO HF. | Direktor/Vorstandsmitglied | 01.01.2021 |
Reykjavik University | Präsident | 01.01.2010 |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Corporate Officer/Principal | 01.01.2007 |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Svafa Grönfeldt
Florida Institute of Technology, Inc. | Graduate Degree |
London School of Economics & Political Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| EMBLA MEDICAL HF. | Health Technology |
| LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
| ICELANDAIR GROUP HF. | Transportation |
| JBT MAREL CORPORATION | Producer Manufacturing |
| Private Unternehmen | 7 |
|---|---|
Landsbankinn hf
 Landsbankinn hf Major BanksFinance Landsbankinn hf engages in the provision of banking and financial services. It operates through the following segments: Personal Banking, Corporate Banking, Markets, Treasury, and Support Functions. The Personal Banking segment provides financial services through the bank’s branch network to individuals and to small and medium-size businesses. The Corporate Banking offers financial services to corporate clients and to small and medium-size businesses. The Markets segment includes brokerage services in securities, foreign currencies and derivatives, securities offerings, and advisory services. The Treasury segment incorporates the bank’s funding and liquidity management, market making in money markets, and determines the bank’s internal pricing. The Support Functions segment consists of finance (excluding treasury), risk management, and information technology; as well as the chief executive officer's office which comprises of human resources, marketing and communications, and compliance. The company was founded in 1886 and is headquartered in Reykjavik, Iceland. | Finance |
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Origo hf
 Origo hf Electronics DistributorsDistribution Services Origo hf engages in the provision of information technology services. It also involves in software development; office equipment distribution; and consultancy and technical services. The company operates through the following segments: End-User Solutions and Related Services; Business Solutions and Infrastructure; and Software Solutions and Services. Origo was founded by Arni Vilhjalmson on April 2, 1992 and is headquartered in Reykjavík, Iceland. | Distribution Services |
The MET Fund LLC
The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Finance |
Marel hf
 Marel hf Industrial MachineryProducer Manufacturing Marel hf engages in the development, manufacture, and sale of equipment for poultry, meat, and fish processing. It operates through the following segments: Poultry Processing, Meat Processing, Fish Processing, and Others. The Poultry Processing segment includes devices for processing broilers, turkeys, and ducks. The Meat Industry segment specializes in slaughtering, cut-up, and deboning solutions for processors supplying products to retail and foodservice. The Fish Processing segment provides equipment, systems, and software for processing whitefish and salmon, both farmed and wild, onboard and ashore. The Others segment deals with the management operations of the firm. The company was founded on March 17, 1983 and is headquartered in Gardabaer, Iceland. | Producer Manufacturing |
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
